 In a population of patients with non-valvular atrial fibrillation NVAF, and treated with oral anticoagulants OAC in routine clinical practice in England, this study will describe patients treated with each OAC, and to estimate and compare event rates of treatment discontinuation, bleeding, and healthcare resource utilisation HCRU across OAC treatments. 